Chennai, June 18 (UNI) Cognizant on Tuesday gave its consent

to acquire Zenith Technologies, a privately-held life sciences

manufacturing technology services company headquartered in

Cork, Ireland.

Zenith Technologies specializes in implementing digital technologies

to manage, control and optimize drug and medical device production

for maximum operational efficiency and regulatory compliance.

The acquisition extends Cognizant’s capabilities for designing,

implementing and managing end-to-end operational and information

technology systems for connected bio-pharmaceutical and medical

device manufacturers.

'The combined Cognizant-Zenith Technologies expertise will deliver

a range of Industry 4.0 capabilities, right from factory design

consultation, machine sensor and controller instrumentation,

supervisory control, and data acquisition, to manufacturing execution

systems, batch automation, enterprise resource planning integration

and managed services', a Cognizant release here said.

The company’s operating hubs in Ireland, Germany, India, Singapore,

the United States and other sites around the world were located near

manufacturing facilities of many Cognizant clients.

Cognizant is a leading services provider to the life sciences industry,

working with all of the world’s top 30 life sciences companies.

It said “Industry 4.0 solutions, encompassing Internet of Things (IoT),

automation and analytics, are a strategic focus area for Cognizant,”

according to Brian Humphries, Chief Executive Officer, Cognizant.

“In acquiring Zenith Technologies, we expand Cognizant’s IoT portfolio

and extend our life sciences domain expertise by becoming a single

source provider of end-to-end smart factory capabilities', he said.

'Together, we are better positioned to help clients realize information

and operational technology convergence in their manufacturing operations,

and advance the development of life-saving drugs, biologics, specialized

pharmaceuticals and medical devices', he added.

UNI GV 1620